Skip to main content
Top
Published in: International Urology and Nephrology 1/2014

01-01-2014 | Nephrology - Case Report

Local ethanol injection for the treatment of deltoid parathyroid cell hyperplasia

Authors: M. Figari, C. G. Musso, L. Plantalech, R. Lambertini, H. Rivera, A. Mollerach

Published in: International Urology and Nephrology | Issue 1/2014

Login to get access

Abstract

Secondary hyperparathyroidism (SHPT) is a serious complication in dialysis patients and is routinely managed with medical therapy. Refractory disease is usually treated either surgically or by local ethanol injection into the parathyroid glands. Total parathyroidectomy with deltoid implant can be successful; however, recurrent, resistant disease is not uncommon. Local ethanol injection was applied to the deltoid autoimplant of a patient with recurrent, resistant SHPT, which had not been resolved with surgical treatment. Serum intact parathyroid hormone (iPTH) levels subsequently decreased from 1,400 to 219 pg/dl and remained stable for the next 6 months. To our knowledge, this procedure has not been previously described in the literature. Local injection of ethanol may represent an interesting alternative to surgery for the treatment of deltoid parathyroid cell hyperplasia in patients in which surgical treatment is not an option.
Literature
1.
go back to reference Polu K, Singh A (2006) Pathogenesis and management of secondary hyperparathyroidism. In: Hsu C (ed) Calcium and phosphate metabolism management in chronic renal disease. Springer, Michigan, pp 29–70 Polu K, Singh A (2006) Pathogenesis and management of secondary hyperparathyroidism. In: Hsu C (ed) Calcium and phosphate metabolism management in chronic renal disease. Springer, Michigan, pp 29–70
2.
go back to reference Clarkson M, Magee C, Brenner B (2010) Disorders of calcium, magnesium, and phosphate balance in the kidney. Saunders, Philadelphia, pp 166–185 Clarkson M, Magee C, Brenner B (2010) Disorders of calcium, magnesium, and phosphate balance in the kidney. Saunders, Philadelphia, pp 166–185
3.
go back to reference Douthat WG, Orozco SE, de Arteaga J, Massari PU (2003) Treatment of refractory secondary hyperparathyroidism with ethanol injection: the importance of glandular volume. Kidney Int Suppl 85:S101–S104PubMedCrossRef Douthat WG, Orozco SE, de Arteaga J, Massari PU (2003) Treatment of refractory secondary hyperparathyroidism with ethanol injection: the importance of glandular volume. Kidney Int Suppl 85:S101–S104PubMedCrossRef
4.
go back to reference Chen HH, Lin CJ, Wu CJ, Lai CT, Lin J, Cheng SP, Yang TL (2011) Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy. Ann Surg 253(4):786–790PubMedCrossRef Chen HH, Lin CJ, Wu CJ, Lai CT, Lin J, Cheng SP, Yang TL (2011) Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy. Ann Surg 253(4):786–790PubMedCrossRef
5.
go back to reference Fassi J, Lambertini R, Farias P, Blejman O, Rosa Diez G, Algranati S, Plantalech L (2005) Treatment of uremic hyperparathyroidism with percutaneous ethanol injection. Nephron Clin Pract 101(2):c53–c57PubMedCrossRef Fassi J, Lambertini R, Farias P, Blejman O, Rosa Diez G, Algranati S, Plantalech L (2005) Treatment of uremic hyperparathyroidism with percutaneous ethanol injection. Nephron Clin Pract 101(2):c53–c57PubMedCrossRef
6.
go back to reference Iovino F, Armano G, Auriemma PP, Sergio R, De Sena G, Capuozzo V, Rosso F, Marino G, Papale F, Grimaldi A, Barbarisi A (2010) Tissue engineering of parathyroid gland. G Chir 31(6–7):312–315PubMed Iovino F, Armano G, Auriemma PP, Sergio R, De Sena G, Capuozzo V, Rosso F, Marino G, Papale F, Grimaldi A, Barbarisi A (2010) Tissue engineering of parathyroid gland. G Chir 31(6–7):312–315PubMed
Metadata
Title
Local ethanol injection for the treatment of deltoid parathyroid cell hyperplasia
Authors
M. Figari
C. G. Musso
L. Plantalech
R. Lambertini
H. Rivera
A. Mollerach
Publication date
01-01-2014
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2014
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-012-0372-0

Other articles of this Issue 1/2014

International Urology and Nephrology 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.